tiprankstipranks
Trending News
More News >
OncoCyte Corp (OCX)
NASDAQ:OCX

OncoCyte (OCX) Revenue

Compare
424 Followers

OncoCyte Revenue

OncoCyte had a revenue of 2.14M in the quarter ending Mar 31, 2025, with 43.88%. This bring the company's revenue in the last twelve months to 3.84M, Decreased 104.31%. In the fiscal year ending Dec 31, 2024, OncoCyte had annual revenue of 1.88M with 25.15% growth.
Revenue (ttm)
3.84M
Revenue Growth
178.08%
P/S Ratio
45.16
Revenue/Employee
$40,891
Employees
46
Market Cap
$84.94M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
1.88M378.00K+25.15%
Dec 31, 2023
1.50M545.00K+56.89%
Dec 31, 2022
958.00K-6.77M-87.60%
Dec 31, 2021
7.73M6.51M+535.44%
Dec 31, 2020
1.22M+∞%
Dec 31, 2019
0.00
Dec 31, 2018
0.00
Dec 31, 2017
0.00
Dec 31, 2016
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis